THE US FDA APPROVALS 1.  Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for AnemiaPublished: 15 May, 2018  | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia2.   Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia  Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA3.  Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…